Trends in radical prostatectomy: Review Article

International Journal of Urology

Volumn 16, Issue 2, 2009, Pages 151-160

  Eastham, James ^a   Tokuda, Yuji ^a   Scardino, Peter ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Nerve sparing; Prostate cancer; Radical prostatectomy; Surgical technique

Indexed keywords

CANCER RISK; CANCER SURGERY; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; INTESTINE FUNCTION; LAPAROSCOPIC SURGERY; MEDICAL PRACTICE; NERVE FUNCTION; NEUROMUSCULAR FUNCTION; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PERIOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SURGEON; SURGICAL TECHNIQUE; UROLOGIC SURGERY;

ERECTILE DYSFUNCTION; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; PHYSICIAN'S ROLE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RECOVERY OF FUNCTION; RISK FACTORS;

EID: 60349130641     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02178.x     Document Type: Review

References (57)

1. Terakawa T, Miyake H, Tanaka K, Takenaka A, Inoue TA, Fujisawa M. Surgical margin status of open versus laparoscopic radical prostatectomy specimens. Int. J. Urol. 2008 15 : 704 7.
2. Hara I, Kawabata G, Tanaka K et al. Oncological outcome of laparoscopic prostatectomy. Int. J. Urol. 2007 14 : 515 20.
3. Schmeller N, Keller H, Janetschek G. Head-to-head comparison of retropubic, perineal and laparoscopic radical prostatectomy. Int. J. Urol. 2007 14 : 402 5.
4. Webster TM, Herrell SD, Chang SS et al. Robotic assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: A prospective assessment of postoperative pain. J. Urol. 2005 174 : 912 14, discussion 14.
5. Hu JC, Wang Q, Pashos CL, Lipsitz SR, Keating NL. Utilization and outcomes of minimally invasive radical prostatectomy. J. Clin. Oncol. 2008 26 : 2278 84.
6. Ahlering TE, Skarecky D, Lee D, Clayman RV. Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: Initial experience with laparoscopic radical prostatectomy. J. Urol. 2003 170 : 1738 41.
7. Herrell SD, Smith JA Jr. Robotic-assisted laparoscopic prostatectomy: What is the learning curve? Urology 2005 66 : 105 7.
8. Begg CB, Riedel ER, Bach PB et al. Variations in morbidity after radical prostatectomy. N. Engl. J. Med. 2002 346 : 1138 44.
9. Eastham JA, Kattan MW, Riedel E et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J. Urol. 2003 170 : 2292 5.
10. Vickers AJ, Bianco FJ, Serio AM et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J. Natl. Cancer Inst. 2007 99 : 1171 7.
11. Walsh PC. Anatomic radical prostatectomy: Evolution of the surgical technique. J. Urol. 1998 160 : 2418 24.
12. Eastham JA. Surgery insight: Optimizing open nerve-sparing radical prostatectomy techniques for improved outcomes. Nat. Clin. Pract. Urol. 2007 4 : 561 9.
13. Eastham JA, Scardino PT. Radical prostatectomy for clinical stage T1 and T2 prostate cancer. In : Vogelzang NJ, Scardino PT, Shipley WU, Coffey DF (eds). Comprehensive Textbook of Genitourinary Oncology, 3rd edn. Baltimore, MD : Lippincott Williams and Wilkins, 2005 166 89.
14. Walsh PC, Donker PJ. Impotence following radical prostatectomy: Insight into etiology and prevention. J. Urol. 1982 128 : 492 7.
15. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. J. Urol. 1991 145 : 998 1002.
16. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J. Urol. 2000 164 : 1929 34.
17. Eichelberg C, Erbersdobler A, Michl U et al. Nerve distribution along the prostatic capsule. Eur. Urol. 2007 51 : 105 10, discussion 10 1.
18. Costello AJ, Brooks M, Cole OJ. Anatomical studies of the neurovascular bundle and cavernosal nerves. BJU Int. 2004 94 : 1071 6.
19. Lunacek A, Schwentner C, Fritsch H, Bartsch G, Strasser H. Anatomical radical retropubic prostatectomy: 'Curtain dissection' of the neurovascular bundle. BJU Int. 2005 95 : 1226 31.
20. Graefen M, Walz J, Huland H. Open retropubic nerve-sparing radical prostatectomy. Eur. Urol. 2006 49 : 38 48.
21. Montorsi F, Salonia A, Suardi N et al. Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy. Eur. Urol. 2005 48 : 938 45.
22. Kaul S, Bhandari A, Hemal A, Savera A, Shrivastava A, Menon M. Robotic radical prostatectomy with preservation of the prostatic fascia: A feasibility study. Urology 2005 66 : 1261 5.
23. Nielsen ME, Marschke P, Walsh PC. High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy. American Urological Association Annual Meeting, Orlando, FL, 2008.
24. Sofer M, Hamilton-Nelson KL, Civantos F, Soloway MS. Positive surgical margins after radical retropubic prostatectomy: The influence of site and number on progression. J. Urol. 2002 167 : 2453 6.
25. Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Myers RP, Blute ML. The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J. Urol. 2004 172 : 1328 32.
26. Ates M, Teber D, Gozen AS et al. Do tumor volume, tumor volume ratio, type of nerve sparing and surgical experience affect prostate specific antigen recurrence after laparoscopic radical prostatectomy? A matched pair analysis. J. Urol. 2007 177 : 1771 5, discussion 1775 6.
27. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years. J. Urol. 1994 152 : 1831 6.
28. Gao X, Mohideen N, Flanigan RC, Waters WB, Wojcik EM, Leman CR. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: Implications for treatment selection. J. Urol. 2000 164 : 1982 6.
29. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001 58 : 843 8.
30. Naya Y, Slaton JW, Troncoso P, Okihara K, Babaian RJ. Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension. J. Urol. 2004 171 : 1093 7.
31. Tsuzuki T, Hernandez DJ, Aydin H, Trock B, Walsh PC, Epstein JI. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination. J. Urol. 2005 173 : 450 3.
32. Menon M, Shrivastava A, Kaul S et al. Vattikuti Institute prostatectomy: Contemporary technique and analysis of results. Eur. Urol. 2007 51 : 648 57, discussion 57 8.
33. Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA. Modified technique for neurovascular bundle preservation during radical prostatectomy: Association between technique and recovery of erectile function. BJU Int. 2008 101 : 1217 22.
34. Kane CJ, Presti JC Jr., Amling CL et al. Changing nature of high risk patients undergoing radical prostatectomy. J. Urol. 2007 177 : 113 17.
35. Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR. Treatment of patients with high risk localized prostate cancer: Results from cancer of the prostate strategic urological research endeavor (CaPSURE). J. Urol. 2005 173 : 1557 61.
36. Denberg TD, Glode LM, Steiner JF, Crawford ED, Hoffman RM. Trends and predictors of aggressive therapy for clinical locally advanced prostate carcinoma. BJU Int. 2006 98 : 335 40.
37. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J. Clin. Oncol. 2005 23 : 8146 51.
38. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005 95 : 751 6.
39. Gerber GS, Thisted RA, Chodak GW et al. Results of radical prostatectomy in men with locally advanced prostate cancer: Multi-institutional pooled analysis. Eur. Urol. 1997 32 : 385 90.
40. Clark PE, Peereboom DM, Dreicer R, Levin HS, Clark SB, Klein EA. Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer. Urology 2001 57 : 281 5.
41. Dreicer R, Magi-Galluzzi C, Zhou M et al. Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer. Urology 2004 63 : 1138 42.
42. Donohue JF, Bianco FJ Jr., Kuroiwa K et al. Poorly differentiated prostate cancer treated with radical prostatectomy: Long-term outcome and incidence of pathological downgrading. J. Urol. 2006 176 : 991 5.
43. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: Influence of concomitant pathological variables. J. Urol. 2002 167 : 117 22.
44. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998 280 : 969 74.
45. Thompson I, Thrasher JB, Aus G et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J. Urol. 2007 177 : 2106 31.
46. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: Role of the urologist. J. Natl. Cancer Inst. 2006 98 : 839 45.
47. Tsai HK, Chen MH, McLeod DG, Carroll PR, Richie JP, D'Amico AV. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer. Cancer 2006 107 : 2597 603.
48. Freedland SJ, Humphreys EB, Mangold LA et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005 294 : 433 9.
49. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005 293 : 2095 101.
50. Berglund RK, Jones JS, Ulchaker JC et al. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: A prospective analysis. Urology 2006 67 : 1253 6.
51. Yossepowitch O, Eggener SE, Bianco FJ Jr. et al. Radical prostatectomy for clinically localized, high risk prostate cancer: Critical analysis of risk assessment methods. J. Urol. 2007 178 : 493 9, discussion 499.
52. Yossepowitch O, Eggener SE, Serio AM et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur. Urol. 2008 53 : 950 9.
53. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J. Urol. 2003 169 : 849 54.
54. Daneshmand S, Quek ML, Stein JP et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results. J. Urol. 2004 172 : 2252 5.
55. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N. Engl. J. Med. 1999 341 : 1781 8.
56. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer. J. Urol. 2004 172 : 1840 4.
57. Touijer K, Rabbani F, Otero JR et al. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1 J. Urol. 2007 178 : 120 4.